The Agilent Technologies-backed tissue analysis device maker has selected the Nasdaq Global Select Market for its initial public offering.

Akoya Biosciences, a US-based tissue analysis technology developer backed by laboratory equipment maker Agilent Technologies, has filed to raise $115m in an initial public offering on the Nasdaq Global Select Market.

Founded in 2015, Akoya has built a tissue analysis technology platform called Codex which allows users to analyse tissue cells and create images of more than 40 protein markers within them at a single-cell resolution.

The technology was developed in a laboratory at Stanford University overseen by Akoya…